» Articles » PMID: 34803426

Saengmaeksan, a Traditional Herbal Formulation Consisting of , Ameliorates Hyperuricemia by Inhibiting Xanthine Oxidase Activity and Enhancing Urate Excretion in Rats

Overview
Journal J Ginseng Res
Date 2021 Nov 22
PMID 34803426
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Saengmaeksan (SMS) is a traditional Korean medicine composed of three herbs, , , and . SMS is used to treat respiratory and cardiovascular disorders. However, whether SMS exerts antihyperuricemic effects is unknown.

Methods: Effects of the SMS extract in water (SMS-W) and 30% ethanol (SMS-E) were studied in a rat model of potassium oxonate-induced hyperuricemia. Uric acid concentrations and xanthine oxidase (XO) activities were evaluated in the serum, urine, and hepatic tissue. Using renal histopathology to assess kidney function and uric acid excretion, we investigated serum creatinine and blood urea nitrogen concentrations, as well as protein levels of renal urate transporter 1 (URAT1), glucose transporter 9 (GLUT9), and organic anion transporter 1 (OAT1). The effects of SMS on XO activity and uric acid uptake were also evaluated. The components of SMS were identified using Ultra Performance Liquid Chromatography (UPLC).

Results: SMS-E reduced serum uric acid and creatinine concentrations, and elevated urine uric acid excretion. SMS-E lowered XO activities in both the serum and liver, and downregulated the expression of renal URAT1 and GLUT9 proteins. SMS-E reduced renal inflammation and IL-1β levels in both the serum and kidneys. SMS-E inhibited both XO activity and urate uptake in URAT1-expressing oocytes. Using UPLC, 25 ginsenosides were identified, all of which were present in higher levels in SMS-E than in SMS-W.

Conclusion: SMS-E exhibited antihyperuricemic effects by regulating XO activity and renal urate transporters, providing the first evidence of its applicability in the treatment of hyperuricemia and gout.

Citing Articles

Anti-hyperuricemia effect of Clerodendranthus spicatus: a molecular biology study combined with metabolomics.

Zhou Z, Xu M, Bian M, Nie A, Sun B, Zhu C Sci Rep. 2024; 14(1):15449.

PMID: 38965392 PMC: 11224374. DOI: 10.1038/s41598-024-66454-7.


Hesperitin-Copper(II) Complex Regulates the NLRP3 Pathway and Attenuates Hyperuricemia and Renal Inflammation.

Peng X, Liu K, Hu X, Gong D, Zhang G Foods. 2024; 13(4).

PMID: 38397567 PMC: 10888018. DOI: 10.3390/foods13040591.


Comparative Assessment of In Vitro Xanthine Oxidase and α-Glucosidase Inhibitory Activities of Cultured Cambial Meristematic Cells, Adventitious Roots, and Field-Cultivated Ginseng.

Zhang T, Liu L, Chen Q, Wang Y, Gao X, Ma X Nutrients. 2024; 16(3).

PMID: 38337727 PMC: 10857066. DOI: 10.3390/nu16030443.


Saengmaeksan, a traditional polyherbal formulation containing Panax ginseng, improves energy metabolism during exercise.

Baek S, Kim J, Nam M, Park S, Lee T, Kang S PLoS One. 2024; 19(1):e0296487.

PMID: 38285695 PMC: 10824426. DOI: 10.1371/journal.pone.0296487.


Effect of on Fatigue, Liver Function, and Immunity Combined with High-Intensity Training.

Juan S, Lee J, Won S, Oh S, Ha M J Immunol Res. 2023; 2023:3269293.

PMID: 37425492 PMC: 10328733. DOI: 10.1155/2023/3269293.


References
1.
Lee Y, Chin Y, Choi Y . Effects of Korean red ginseng extract on acute renal failure induced by gentamicin and pharmacokinetic changes by metformin in rats. Food Chem Toxicol. 2013; 59:153-9. DOI: 10.1016/j.fct.2013.05.025. View

2.
Zhang Y, Su H, Zhang J, Kong J . The Effects of Ginsenosides and Anserine on the Up-Regulation of Renal Aquaporins 1-4 in Hyperuricemic Mice. Am J Chin Med. 2019; 47(5):1133-1147. DOI: 10.1142/S0192415X19500587. View

3.
Singh J, Reddy S, Kundukulam J . Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol. 2011; 23(2):192-202. PMC: 4104583. DOI: 10.1097/BOR.0b013e3283438e13. View

4.
Tang D, Ye Y, Wang C, Li Z, Zheng H, Ma K . Potassium oxonate induces acute hyperuricemia in the tree shrew (tupaia belangeri chinensis). Exp Anim. 2017; 66(3):209-216. PMC: 5543241. DOI: 10.1538/expanim.16-0096. View

5.
Strilchuk L, Fogacci F, Cicero A . Safety and tolerability of available urate-lowering drugs: a critical review. Expert Opin Drug Saf. 2019; 18(4):261-271. DOI: 10.1080/14740338.2019.1594771. View